Dexamethasone Versus Dexmedetomidine

• Status: Completed
• Trial end date: 2018-04-30
• Target enrollment: 0
• Participant gender: Female

Summary

The transversus abdominis plane (TAP) block is most often used to provide surgical anesthesia for minor, superficial procedures on the lower abdominal wall, or postoperative analgesia for procedures below the umbilicus providing anesthesia to the ipsilateral lower abdomen below the umbilicus.

In a recent meta-analysis, the TAP block was shown to reduce the need for postoperative opioid use, increase the time to the first request for further analgesia, and provide more effective pain relief, while decreasing opioid-related side effects such as sedation and postoperative nausea and vomiting. The provision of effective postoperative analgesia is of key importance to facilitate early ambulation and prevention of postoperative morbidity. The analgesic regimen needs to meet the goals of providing safe, effective analgesia, with minimal side effects. Many additives to local anesthetics used to prolong the duration of analgesia for peripheral nerve blocks have been studied as dexamethasone, dexmedetomidine Dexmedetomidine is a lipophilic α2 agonist derivative with a higher affinity for α2-receptors than clonidine (α2: α1 specificity ratio is 200:1 for clonidine and 1600:1 for dexmedetomidine). It has sedative, analgesic, and sympatholytic effects that blunt many of the cardiovascular responses seen during the perioperative period. Animal and human studies have shown safety and efficacy of adding dexmedetomidine to local anesthetics in various regional anesthetic procedures. The addition of dexmedetomidine to bupivacaine in TAP block achieves better local anesthesia and provides better pain control postoperatively without any major side-effects.

Dexamethasone is a systemic glucocorticoid that improves the quality of recovery after surgery by reducing pain, nausea, and vomiting. When added to local anesthetics as an adjuvant in peripheral blocks, it prolongs the analgesia time. Mechanism of action may be through the anti-inflammatory action, the increase of the local efficiency, and to slow down of the absorption.

Objective:

The objective is to compare and evaluate efficacy and safety of dexmedetomidine and dexamethasone as a local anesthetic adjuvant to bupivacaine in ultrasound-guided TAP block for patients scheduled for total abdominal hysterectomies.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Fayoum University Hospital
• Treatments: Adjuvants, Anesthesia; Anesthetics; Anesthetics, Local; BB 1101; Bupivacaine; Dexamethasone; Dexamethasone acetate; Dexmedetomidine; Pharmaceutical Solutions

Criteria

Inclusion Criteria:

• American society of anesthesiologists (ASA) physical status grade 1 and 2.

• Age of 18 years and more.

• Patients who will be scheduled for total abdominal hysterectomies.

Exclusion Criteria:

• Patient refusal.

• Body mass index (BMI) > 40.

• Patients with chronic pain and those using chronic analgesic medications.

• Coagulopathy.

• Allergy to the study drugs.

• Patients taking other medications with α-adrenergic blocking effect.

• Hepatic or renal insufficiency.

• Systemic infection.

• Infection at the site of injection.